首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Neurocognitive functioning in children with mild and moderate asthma in the childhood asthma management program. The Childhood Asthma Management Program (CAMP) Research Group.
【24h】

Neurocognitive functioning in children with mild and moderate asthma in the childhood asthma management program. The Childhood Asthma Management Program (CAMP) Research Group.

机译:儿童哮喘管理程序中的轻度和中度哮喘儿童的神经认知功能。儿童哮喘管理计划(CAMP)研究组。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The Childhood Asthma Management Program (CAMP) is a multicenter double-blind, randomized, placebo-controlled, clinical trial of two anti-inflammatory agents and placebo in children with mild and moderate asthma. OBJECTIVE: The interrelationship between asthma severity and neurocognitive functioning among 1041 children (age range, 5-12 years) enrolled in the CAMP trial was examined. METHODS: Asthma severity was established at baseline with a clinical history of asthma symptomatology and measures of lung function (spirometry and methacholine challenge). Diary cards were used in a screening to record nighttime awakenings and doctor contacts caused by asthma symptoms, symptom severity, and number of puffs from a rescue inhaler. All children received a comprehensive neurocognitive assessment at the end of the 28-day screening period (before randomization), including measures of intelligence, attention, memory, and academic achievement. RESULTS: Significant differences were found between children with mild and moderate asthma on lung function and symptom outcome variables (log(e)FEV(1)PC(20), DeltaFEV(1) percent predicted, change in peak flow percent predicted, nighttime awakenings caused by asthma, average symptom severity score, and average daily number of puffs from a rescue inhaler) but not on neurocognitive variables. Multiple regression analyses revealed that asthma outcomes could not be predicted by neurocognitive variables despite controlling for socioeconomic status. The prevalence of neurocognitive dysfunction, as indicated by the use of psychostimulant medication, was found to be consistent with that found in the existing literature. CONCLUSION: Mild and moderate asthma symptoms are not related to neurocognitive functioning in the children enrolled in CAMP. Mean performance on neurocognitive variables was found to be similar to that of national normative data.
机译:背景:儿童哮喘管理计划(CAMP)是针对轻度和中度哮喘患儿的两种抗炎药和安慰剂的多中心,双盲,随机,安慰剂对照临床试验。目的:研究了参加CAMP试验的1041名儿童(5-12岁)的哮喘严重程度与神经认知功能之间的相互关系。方法:哮喘的严重程度是在基线时确定的,具有哮喘症状的临床病史和肺功能的测量值(肺活量测定法和乙酰甲胆碱激发)。使用日记卡进行筛查,以记录夜间醒来和由哮喘症状,症状严重程度和急救吸入器引起的抽吸次数引起的医生联系。在28天的筛选期结束时(随机分组之前),所有儿童均接受了全面的神经认知评估,包括智力,注意力,记忆力和学习成绩的测量。结果:轻度和中度哮喘患儿的肺功能和症状结果变量之间存在显着差异(log(e)FEV(1)PC(20),DeltaFEV(1)预测百分比,峰值流量预测百分比变化,夜间觉醒由哮喘,平均症状严重程度评分和急救吸入器的平均每日抽吸次数引起),但与神经认知变量无关。多元回归分析显示,尽管控制了社会经济状况,但神经认知变量无法预测哮喘的预后。如使用精神刺激药所表明的那样,发现神经认知功能障碍的患病率与现有文献一致。结论:轻度和中度哮喘症状与参加CAMP的儿童的神经认知功能无关。发现神经认知变量的平均表现与国家标准数据相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号